Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEVI-D for androgen receptor-positive advanced solid tumors
ACTRN12618001074280Phase 2Recruiting
- Sponsor
- St Vincent's Hospital
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of seribantumab and dexamethasone, sponsored by St Vincent's Hospital. Started Aug 2018; status: recruiting.
02
Drugs
seribantumabdexamethasone
Beyond the preview
Go deeper on ACTRN12618001074280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001074280.